Abstract
A NEW and important member of the arachidonate–thromboxane–prostaglandin system, prostacyclin (PGI2), has recently been isolated1–3. This bicyclic prostaglandin has been shown to be synthesised from the prostaglandin endoperoxides PGG2 and PGH2, by arteries, veins, heart and other tissues in several species, including man1–7. PGI2 is a powerful inhibitor of platelet aggregation and relaxes arterial strips1,2,4,5. It is 30 times more potent than PGE1 as an inhibitor of platelet aggregation, and in the intact dog promotes a dramatic reduction in systemic blood pressure1,2,8,9. It has also been suggested that PGI2 is a potent coronary vasodilator and anti-atherogenic compound10–12, and that it plays an essential part in the homeostasis of the cardiovascular system1,2,4,5,11,12. The kidneys receive a large portion of the cardiac output and have an extensive vascular tree, and so PGI2 may be extremely significant in regulating kidney function. Human and rabbit renal cortical microsomes have been found to convert PGG2 to PGI2 (ref. 13), but nothing is known of the renal effects of PGI2. Therefore, this study was designed to evaluate the effects and significance of an intrarenal infusion of PGI2 on renal haemodynamics, urinary function and renal vein plasma renin activity, and to compare these effects with those produced by PGE2 and PGD2, two prostaglandins known to be synthesised by the kidney and to affect renal function.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Gryglewski, R. J., Bunting, S., Moncada, S., Flower, R. J. & Vane, J. R. Prostaglandins 12, 685–713 (1976).
Bunting, S., Gryglewski, R., Moncada, S. & Vane, J. R. Prostaglandins 12, 897–913 (1976).
Pace-Asciak, C. R. & Nashat, M. Biochim. biophys. Acta 487, 495–507 (1977).
Moncada, S., Gryglewski, R., Bunting, S. & Vane, J. R. Nature 263, 663–665 (1976).
Moncada, S., Higgs, E. A. & Vane, J. R. Lancet i, 18–21 (1977).
Pace-Asciak, C. R. & Rangaraj, G. Biochim. biophys. Acta 486, 579–582 (1977).
Chang, W.-C. & Murata, S.-I. Biochim. biophys. Acta 486, 136–144 (1977).
Fitzpatrick, T. M. et al. Circulation Res. (in the press).
Armstrong, J. M. et al. Br. J. Pharmac. 61, 136P (1977).
Raz, A., Isakson, P. C., Minkes, M. S. & Needleman, P. J. biol. Chem. 252, 1123–1126 (1977).
Needleman, P., Kulkarni, P. S. & Raz, Ann. Sci. 195, 409–412 (1977).
Villa, S., Mysliwiec, M. & de Gaetano, G. Lancet i, 1216–1217 (1977).
Whorton, A. R., Smigel, M., Oates, J. A. & Frolich, J. C. Prostaglandins 13, 1021 (1977).
Bolger, P. M., Eisner, G. M., Shea, P. T., Ramwell, P. W. & Slotkoff, L. M. Nature 267, 628–630 (1977).
Waldman, H. M., Alter, I., Kot, P. A., Rose, J. C. & Ramwell, P. W. J. Pharmac. exp. Ther. (in the press).
Chang, L. C. T., Splawinski, J. A., Oates, J. A. & Nies, A. S. Circulation Res. 36, 204–207 (1975).
Stein, J. H., Ferris, T. F., Huprich, J. E., Smith, T. C. & Osgood, R. W. J. clin. Invest. 50, 1429–1438 (1971).
Kauker, M. L. Proc. Soc. exp. Biol. Med. 154, 274–277 (1977).
Stokes, J. & Kokko, J. J. clin. Invest. 59, 1099–1104 (1977).
Vander, A. J. Am. J. Physiol. 214, 218–221 (1968).
Yun, J., Kelly, G., Bartter, F. C. & Smith, H. Circulation Res. 40, 459–464 (1977).
Bartter, F. C. Prostaglandins Therapeutics 3, 2–4 (1977).
Vander, A. J. & Miller, R. Am. J. Physiol. 207, 537–545 (1964).
Thurau, K. W. C., Dahlheim, H., Gruner, A., Mason, J. & Granger, P. Circulation Res. 30–31, Suppl. II, II–182–II–186, (1972).
Corey, E. J., Keck, G. E. & Szekely, I. J. Am. chem. Soc. 99, 2006–2008 (1977).
Slotkoff, L. M., Logan, A., Jose, P., D'Avella, J. & Eisner, G. M. Circulation Res. 28, 158–166 (1971).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
MICHAEL BOLGER, P., EISNER, G., RAMWELL, P. et al. Renal actions of prostacyclin. Nature 271, 467–469 (1978). https://doi.org/10.1038/271467a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/271467a0
This article is cited by
-
Functional response of the rat kidney to inhibition of nitric oxide synthesis: role of cytochrome P450‐derived arachidonate metabolites
British Journal of Pharmacology (1998)
-
Opposite renal effects of a PGE1 analog and prostacyclin in humans
Kidney International (1994)
-
Thromboxane and prostacyclin differentially regulate murine extracellular matrix gene expression
Kidney International (1993)
-
Endothelial factors in the regulation of renin release
Kidney International (1990)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.